ARCHIVES

Senate Confirms McClellan For FDA

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

FDA Oncology Division To Develop Papers On Expectations for New Drugs

August 2, 1996

Southern Screening Contract Now at $2 Mil. Year For Five Year

June 7, 1974

Eight States Get Cervical Cancer Screening Planning Contracts

June 21, 1974

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

September 13, 2002